DESCRIPTION
Conferences take place on Orange Wednesday mornings at 7:00 am - 8:00 am. Exceptions will be noted in the notifications.

TARGET AUDIENCE
This course is intended primarily for Urology and Nephrology physicians and mid-level providers, as well as nutrition services.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

• Recognize and review the differential diagnosis.
• Analyze and critique different solutions for medical management of the cases.
• Appraise and examine consequences of different treatment plans leading to a recommendation. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS (added 10/11/2023)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Christopher Wolter, M.D.- IMARC: Clinical Events Committee for TRANSFORM UUI trial, Hologic
Mitchell Humphreys, M.D, - Consulting – Johnson and Johnson, Virtuoso, Boston Scientific. Grant/Research Support - Boston Scientific, Cook Urologic, Adva-Tec.
Karen Stern, M.D. - Consulting - Coloplast, Calyxo (added 2-10-22)

All relevant financial relationships have been mitigated.